Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,447 INR | -1.32% | -2.64% | +16.12% |
31/05 | Cipla's Global Chief Technology Officer Retires | MT |
30/05 | India's pharma export sales to grow faster this year, trade body says | RE |
Sales 2024 | 26TCr 309.01Cr | Sales 2025 * | 28TCr 335.54Cr | Capitalization | 1,16900Cr 1.4TCr |
---|---|---|---|---|---|
Net income 2024 | 4.12TCr 49Cr | Net income 2025 * | 4.66TCr 56Cr | EV / Sales 2024 | 4.69 x |
Net cash position 2024 * | 5.58TCr 67Cr | Net cash position 2025 * | 5.74TCr 69Cr | EV / Sales 2025 * | 3.97 x |
P/E ratio 2024 |
29.3
x | P/E ratio 2025 * |
25.1
x | Employees | 32,323 |
Yield 2024 * |
0.58% | Yield 2025 * |
0.68% | Free-Float | 67.03% |
Latest transcript on Cipla Limited
1 day | -1.32% | ||
1 week | -2.64% | ||
1 month | +3.37% | ||
3 months | -2.24% | ||
6 months | +19.38% | ||
Current year | +16.12% |
Managers | Title | Age | Since |
---|---|---|---|
Umang Vohra
CEO | Chief Executive Officer | 52 | 01/15/01 |
Ashish Adukia
DFI | Director of Finance/CFO | - | 16/22/16 |
Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ashok K. Sinha
BRD | Director/Board Member | 72 | 16/13/16 |
Chairman | 87 | 21/72/21 | |
Director/Board Member | 83 | 16/77/16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 6 M€ | +6.07% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 1,447 | -1.32% | 3,270,743 |
30/24/30 | 1,467 | -1.80% | 1,732,140 |
29/24/29 | 1,494 | +0.95% | 1,607,691 |
28/24/28 | 1,479 | +0.05% | 784,496 |
27/24/27 | 1,479 | -0.52% | 1,393,334 |
Delayed Quote NSE India S.E., May 31, 2024 at 05:13 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.12% | 1.4TCr | |
+15.91% | 4.2TCr | |
+22.40% | 2.23TCr | |
+18.48% | 1.52TCr | |
+45.12% | 1.21TCr | |
-0.05% | 678.76Cr | |
-9.58% | 679.6Cr | |
-8.87% | 572.55Cr | |
+14.18% | 549.33Cr | |
+4.17% | 462.48Cr |
- Stock Market
- Equities
- CIPLA Stock